Cargando…

Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice

Bacterial translocation (BT) and splenomegaly contribute to cirrhosis-associated immune dysfunction (CAID) including T cell depletion, infection, and chronic inflammation. β-blockers have been reported to decrease BT and improve splenomegaly. This study explores the modulation of β1 and β2 adrenergi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Hung-Cheng, Hsu, Chien-Fu, Huang, Chia-Chang, Huang, Shiang-Fen, Li, Tzu-Hao, Yang, Ying-Ying, Lin, Ming-Wei, Lee, Tzung-Yan, Liu, Chih-Wei, Huang, Yi-Hsiang, Hou, Ming-Chih, Lin, Han-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140430/ https://www.ncbi.nlm.nih.gov/pubmed/32138352 http://dx.doi.org/10.3390/cells9030604

Ejemplares similares

Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis
por: Li, Tzu-Hao, et al.
Publicado: (2020)

Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice
por: Chou, Yu-Te, et al.
Publicado: (2021)

Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats
por: Liu, Szu-Yu, et al.
Publicado: (2021)

SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice
por: Liu, Chih-Wei, et al.
Publicado: (2020)

TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients
por: Fan, Wen-Chien, et al.
Publicado: (2016)

Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches
por: Tsai, Yu-Lien, et al.
Publicado: (2020)

Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice
por: Tsai, Hung-Cheng, et al.
Publicado: (2019)

Prognosis of critically ill cirrhotic versus non-cirrhotic patients: a comprehensive score-matched study
por: Fu, Chung-Ming, et al.
Publicado: (2014)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study
por: Li, Tzu-Hao, et al.
Publicado: (2021)

Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model
por: Su, Yen-Bo, et al.
Publicado: (2018)

Propranolol Reduces Cancer Risk: A Population-Based Cohort Study
por: Chang, Ping-Ying, et al.
Publicado: (2015)

Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices
por: Zhang, Feng, et al.
Publicado: (2019)

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats
por: Chang, Ching-Chih, et al.
Publicado: (2019)

The Diminished Expression of Proangiogenic Growth Factors and Their Receptors in Gastric Ulcers of Cirrhotic Patients
por: Luo, Jiing-Chyuan, et al.
Publicado: (2013)

The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
por: Yeh, Wen-Shuo, et al.
Publicado: (2019)

Early echocardiographic signs of diastolic dysfunction predict acute kidney injury in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2020)

The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study
por: Chang, Ping-Ying, et al.
Publicado: (2019)

The Risk of Cellulitis in Cirrhotic Patients: A Nationwide Population-Based Study in Taiwan
por: Lin, Ming-Nan, et al.
Publicado: (2012)

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats
por: Huang, Hui-Chun, et al.
Publicado: (2022)

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats
por: Pun, Chon Kit, et al.
Publicado: (2021)

Risk Models and Scoring Systems for Predicting the Prognosis in Critically Ill Cirrhotic Patients with Acute Kidney Injury: A Prospective Validation Study
por: Pan, Heng-Chih, et al.
Publicado: (2012)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Prognostic factors of cirrhotic patients with invasive fungal infections
por: Hung, Tsung-Hsing, et al.
Publicado: (2023)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

Acute Kidney Injury Classification for Critically Ill Cirrhotic Patients: A Comparison of the KDIGO, AKIN, and RIFLE Classifications
por: Pan, Heng-Chih, et al.
Publicado: (2016)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

The long-term outcomes of cirrhotic patients with pleural effusion
por: Hung, Tsung-Hsing, et al.
Publicado: (2018)

Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization
por: Hung, Tsung-Hsing, et al.
Publicado: (2021)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Identification of hot regions in protein-protein interactions by sequential pattern mining
por: Hsu, Chen-Ming, et al.
Publicado: (2007)

Prediction models combining zonulin, LPS, and LBP predict acute kidney injury and hepatorenal syndrome–acute kidney injury in cirrhotic patients
por: Lin, Yi-Hsuan, et al.
Publicado: (2023)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease
por: Chou, Che-Yi, et al.
Publicado: (2016)

Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma
por: Huang, Chun-Ming, et al.
Publicado: (2015)

High Mortality of Cirrhotic Patients With End-Stage Renal Disease
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized Rats
por: Teong, Benjamin, et al.
Publicado: (2017)

Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats
por: Li, Tzu-Hao, et al.
Publicado: (2016)

Measurement of Variceal Pressure with a Computerized Endoscopic Manometry: Validation and Effect of Propranolol Therapy in Cirrhotic Patients
por: Kong, De-Run, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5p8htkksuhpupj6l4t8ndfdimo